Maverick Capital’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-29,594	Closed	-$1.95M	–	249
2024 Q3	$1.95M	Buy	+29,594	New	+$2.15M	0.04%	125
2024 Q1	–	Sell	-2,977	Closed	-$227K	–	456
2023 Q4	$227K	Sell	2,977 -2,331	-44%	-$162K	﹤0.01%	323
2023 Q3	$368K	Buy	5,308 +990	+23%	+$79.6K	0.01%	203
2023 Q2	$407K	Sell	4,318 -2,815	-39%	-$245K	0.01%	280
2023 Q1	$590K	Buy	7,133 +3,511	+97%	+$276K	0.02%	212
2022 Q4	$270K	Sell	3,622 -10,616	-75%	-$818K	0.01%	313
2022 Q3	$1.18M	Buy	+14,238	New	+$1.37M	0.03%	127
2020 Q4	–	Sell	-15,652	Closed	-$1.25M	–	710
2020 Q3	$1.25M	Sell	15,652 -14,889	-49%	-$1.16M	0.02%	223
2020 Q2	$2.11M	Buy	+30,541	New	+$2.17M	0.04%	169
2018 Q4	–	Sell	-117,480	Closed	-$6.82M	–	272
2018 Q3	$6.82M	Sell	117,480 -188,040	-62%	-$9.2M	0.08%	130
2018 Q2	$14.8M	Buy	305,520 +81,090	+36%	+$3.78M	0.17%	61
2018 Q1	$10.4M	Sell	224,430 -13,950	-6%	-$606K	0.13%	93
2017 Q4	$8.96M	Buy	238,380 +100,710	+73%	+$3.7M	0.11%	66
2017 Q3	$5.02M	Buy	137,670 +36,630	+36%	+$1.4M	0.06%	76
2017 Q2	$3.98M	Buy	101,040 +8,370	+9%	+$306K	0.05%	64
2017 Q1	$2.91M	Sell	92,670 -22,650	-20%	-$709K	0.04%	49
2016 Q4	$3.6M	Buy	115,320 +34,620	+43%	+$1.12M	0.05%	34
2016 Q3	$3.24M	Sell	80,700 -16,200	-17%	-$610K	0.04%	48
2016 Q2	$3.22M	Buy	+96,900	New	+$3.32M	0.04%	43
2015 Q3	–	Sell	-11,760	Closed	-$279K	–	123
2015 Q2	$279K	Hold	11,760	–	–	﹤0.01%	64
2015 Q1	$279K	Buy	+11,760	New	+$264K	﹤0.01%	67